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ABSTRACT
A 40-year-old male patient with no significant medical history was admitted with an inferior STsegment elevation myocardial infarction. Primary percutaneous coronary intervention revealed a
right coronary artery aneurysm, with no evidence of significant coronary disease. We support the
hypothesis of aneurysmal thrombus formation with distal embolization.
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INTRODUCTION
A coronary artery aneurysm (CAA) is a localized dilation of the coronary vasculature
of at least 1.5 times the diameter of an adjacent normal segment, which is a relatively
uncommon finding in coronary angiography. CAA-associated ST-segment elevation
myocardial infarction (STEMI) is rarely encountered in clinical practice and presents a
management challenge1 . Current guidelines lack recommendations regarding medical
therapy for patients with CAA2 . Reports indicate that two-thirds of patients presenting
with CAA are empirically managed with dual antiplatelet therapy. Nevertheless,
retrospective data claim that intense antithrombotic therapy is associated with better
outcomes3 . Due to the scarcity of recommendations and varied coronary anatomy,
management plans remain individualized according to patient presentation, inherent
CAA morphology, and complication risk.

Case presentation
A 40-year-old male patient with a history of gout presented with acute onset of severe
and persistent chest pain, which was associated with sweating, pain radiation to the
left arm with a tingling sensation, and concurrent acute-onset diarrhea. Emergency
medical service was called, troponin peak was 45,909 (<=27 ng/L normal) with EKG
readings consistent with ST-elevation myocardial infarction (STEMI). The patient was then
transferred to the catheterization lab for further management.
Transthoracic echocardiography (TTE) showed mild left ventricular (LV) dilatation
with hypokinesia of the inferolateral wall, with an ejection fraction of 69%. A coronary
angiogram demonstrated normal left main coronary artery, left anterior descending
(LAD), and left circumflex (Figure 1A), an isolated mid-right coronary artery (RCA)
aneurysm, and mid-distal thrombotic occlusion of the RCA just proximal to takeoff
of the posterior descending artery (PDA) branch (Figure 2B). The patient underwent
percutaneous intervention in which the RCA was wired with some difficulty using Fielder
FC wire (Figure 2A). The occluded area was ballooned with a 2.0 mm balloon with
restoration of flow into the PDA (Figure 2B). Posterolateral branches were not observed
(Figure 2C). The distal occlusion was stented with a 2.5 × 18 mm Resolute Onyx (drugeluting) stent. A proximal large diameter segment with residual stenosis was stented with
a 3.5 mm × 8 mm Resolute Onyx (drug-eluting) (Figure 2D). Postoperative angiographic
results demonstrated 0% residual stenosis with no evidence of posterolateral branches in

Figure 1. Coronary angiography showing normal LMCA and left main branches (A). Aneurysmal
Mid-RCA with thrombotic occlusion of the distal vessel (B).
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Figure 2. RCA angiogram. (A) RCA wiring with a Fielder FC wire. (B) PDA flow restoration following
ballooning. (C) No visible posterolateral flow. D: Distal RCA following stent deployment demonstrating no
residual stenosis.

multiple views. The patient had an uneventful course of treatment with no postoperative
complications and was discharged on aspirin and Plavix dual antiplatelet therapy (DAPT)
for one year.

DISCUSSION
CAA has a 0.3−5.3% incidence rate, with a mean incidence of 1.65% from the pooled
analysis3 . Men tend to be more predisposed than women with an underlying
atherosclerotic coronary artery disease (CAD) deemed the most common risk of
developing CAA in the adult population, while Kawasaki disease is in the pediatric
population. Notably, growing adults with late manifestations of Kawasaki disease
might also have the propensity to develop CAA. Other risk factors include connective
tissue disease and infectious diseases. In 2009, Jha et al. demonstrated a modest RCA
propensity for aneurysmal formation over the LAD (19 RCA vs. 10 LAD) with no apparent
underlying reason5 . Although CAA is most commonly an incidental finding, this can be
complicated by thrombosis and distant embolism. Aneurysmal dilatation is associated
with stagnant coronary blood flow, predisposing patients to the development of acute
thrombus formation, presenting as angina, ischemia, or STEMI. Coronary angiography
plays a vital role in the diagnosis of CAA. Cardiac intravascular ultrasound can be a
valuable tool in the characterization of luminal components of aneurysms and can
differentiate between true and pseudo-aneurysmal dilatations4 .
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To date, there is a lack of consensus regarding CAA management. Nevertheless,
guideline-directed medical management remains the treatment of choice for CAA
associated with a background of atherosclerotic CAD. Should thrombosis/embolism
raise any concern, DAPT with anticoagulants should be indicated, similar to the present
case5 . This decision should be balanced by considering the patient’s bleeding risks.
Rivaroxaban with DAPT is a better alternative than vitamin K antagonists and DAPT in
terms of bleeding risk, as PIONEER AF-PCI demonstrated a lower risk of bleeding in
the former. Similar to CAD, matrix metalloproteinase and inflammatory cytokines have
also been linked to CAA, suggesting the role of statin therapy in halting aneurysmal
progression6 . Surgical modalities may be indicated in cases where a large saccular
aneurysm is identified (>10 mm), which tends to present a risk of rupture. Modalities
include aneurysmectomy with or without coronary bypass grafting and aneurysmal
ligation/resection.
Our case is of further interest as there was no associated CAD with RCA aneurysmal
finding. This finding made the theory of aneurysmal thrombus formation with distant
embolization sound plausible. The management of patients with CAA-associated STEMI
poses a challenge and can be associated with high-risk complications. Despite the
successful revascularization outcome in this case, revascularization of an aneurysmal
coronary artery vessel has a relatively low success rate and carries >15% risk rate of
stent re-thrombosis at one year7 . Therefore, revascularization of an aneurysmal culprit
vessel should focus on anterograde reperfusion as a primary objective, followed by stent
implantation. The current percutaneous recommendations for CAA-associated STEMI
are presented in (Figure 3)2 . However, it is important to understand the nature of CAA
development. In the case of stenotic aneurysms associated with Kawasaki disease,
lesions were shown to be highly calcified which may require a different management
strategy from typical atherosclerotic lesions including rotational atherectomy since the
use of high balloon pressure with angioplasty can lead to aneurysmal formation8–10 .

Figure 3. Treatment algorithm for ST-segment elevation acute myocardial infarction (STEMI)
caused by coronary artery aneurysm. The primary objective should be a return of anterograde
circulation and thrombus burden reduction. Intravascular ultrasound (IVUS) may play a role in
understanding the base mechanism, vessel sizing and optimize stent implantation. AF = atrial fibrillation;
DES = drug-eluting stent; PCI = percutaneous coronary intervention; TIMI = Thrombolysis In Myocardial
Infarction. Reproduced under CC BY license from2 .
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What have we learned?
• Coronary artery aneurysms have a predilection to develop in right coronary artery
affecting 40–70% of cases and tend to be associated with multi-vessel atherosclerotic
coronary artery disease.
• Medical management still constitutes the preferred management for coronary artery
aneurysms in the setting of atherosclerosis.
• Further studies are needed to investigate the optimal management of artery
aneurysm.
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